Medication info
Atorowojung 10mg (Atorvastatin Calcium Trihydrate)

Atorowojung 10mg (Atorvastatin Calcium Trihydrate)

Prescription medicationTabletOral
Ingredient · strength
Atorvastatin Calcium Trihydrate›10.85mg / 1 tablet
Manufacturer / importer
Samchundang Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200709786 · Notified 2007.08.24 · Insurance code 651202710

Summary

Main use
Improvement of hyperlipidemia (including familial hyperlipidemia) and prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)
Who takes it
Adults · Children
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medication may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended starting dose is 10 mg of atorvastatin once daily. However, patients who require a greater reduction in LDL cholesterol may start at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or greater is required). This medication is administered once daily at doses ranging from 10 ~ 80 mg. The initial and maintenance doses of this medication should be individualized according to the patient's characteristics, taking treatment goals and response into consideration. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Since the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use at the start of treatment and when evaluating the treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia This medication is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: The efficacy and safety in patients aged 70 years or older are similar to those in the general adult patient population.
Child dose
2. Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended starting dose is 10 mg of this medication once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this medication greater than 20 mg in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer.

Ingredients

Manufacturer
Samchundang Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia (including familial hyperlipidemia) and prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)

  • Coronary artery heart disease
  • myocardial infarction
  • stroke
  • chronic stable angina
  • retinopathy
  • albuminuria
  • congestive heart failure
  • hyperlipidemia
  • primary hypercholesterolemia
  • mixed dyslipidemia
  • abnormal beta-lipoproteinemia
  • elevated serum triglycerides
View approved original text

This medication is primarily used to reduce the risk of cardiovascular diseases. It is particularly helpful in reducing the risk of conditions such as myocardial infarction, stroke, and angina in adults with cardiovascular risk factors and patients with type 2 diabetes. Additionally, it lowers the risk of myocardial infarction, stroke, need for vascular intervention, hospitalization due to congestive heart failure, and angina in patients already diagnosed with cardiovascular diseases. In patients with hyperlipidemia, it is used to reduce total cholesterol, LDL cholesterol, apo-B protein, and triglyceride levels, while increasing HDL cholesterol levels to improve blood lipid status. Furthermore, it acts as an adjunct to reduce total cholesterol and LDL cholesterol levels in adolescents with familial hypercholesterolemia that is not controlled by diet alone. Thus, this medication is effective for the reduction of cardiovascular disease risk and improvement of dyslipidemia, contributing to the enhancement of patient health.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medication may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended starting dose is 10 mg of atorvastatin once daily. However, patients who require a greater reduction in LDL cholesterol may start at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or greater is required). This medication is administered once daily at doses ranging from 10 ~ 80 mg. The initial and maintenance doses of this medication should be individualized according to the patient's characteristics, taking treatment goals and response into consideration. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Since the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use at the start of treatment and when evaluating the treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia This medication is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: The efficacy and safety in patients aged 70 years or older are similar to those in the general adult patient population.

Child dose

2. Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended starting dose is 10 mg of this medication once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this medication greater than 20 mg in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer.

Precautions

This medication can cause muscle-related issues, so if symptoms such as muscle pain or weakness occur, treatment should be discontinued immediately and a physician consulted. This medication should not be used in patients with certain liver diseases or severely impaired liver function and regular liver function tests should be performed before and during treatment. Women who are pregnant, may become pregnant, or are breastfeeding should not take this medication, and women of childbearing potential should use appropriate contraceptive methods during treatment. This medication should not be used in children under 10 years of age, and should be used cautiously under the judgment of a physician in children aged 10 to 17 years. Patients with a history of alcoholism or liver disease, and those with impaired kidney function, should use this medication with greater caution and require regular monitoring. Interaction may occur when co-administering with other medications, so if currently taking other drugs, it is essential to inform a physician or pharmacist. Caution is required when taken with certain antibiotics, antifungals, antivirals, antihypertensives, and antidiabetics, and particularly when taken with drugs that inhibit CYP3A4 enzymes, as this may increase the risk of side effects. There is no specific antidote for overdose, so the dosage should be strictly adhered to and if any unusual symptoms occur, a medical institution should be visited immediately. This medication should be stored out of reach of children and kept in the original container for safety. If allergic reactions such as skin rashes, hives, itching, or difficulty breathing occur during treatment, stop taking the medication immediately and consult a physician. This medication may raise blood glucose levels, so patients at risk of diabetes should manage their blood sugar carefully, and if severe muscle pain or weakness occurs, they should inform healthcare providers immediately. Elderly patients or those with kidney disease have a higher risk of muscle-related complications and require careful monitoring during treatment. Consuming grapefruit juice can increase the blood concentration of this medication and heighten the risk of side effects, so it is recommended to avoid grapefruit juice.

Side effects

  • Weakness
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • nasopharyngitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 181 more
  • loss of appetite
  • constipation
  • abdominal bloating
  • indigestion
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngitis
  • laryngitis
  • epistaxis
  • insomnia
  • nightmares
  • headache
  • dizziness
  • perceptual disturbances
  • sensory loss
  • taste disturbances
  • amnesia
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications due to rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • thrombocytopenia
  • vasculitis
  • allergic reactions
  • anaphylaxis
  • hepatitis
  • cholestasis
  • hepatic failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • vascular neurogenic edema
  • erythema multiforme
  • skin and mucous membrane syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • elevated serum CK
  • positive urinary leukocytes
  • thrombocytopenia
  • leukopenia
  • anemia
  • decreased testosterone
  • elevated cholinesterase
  • elevated TSH
  • elevated ACTH
  • decreased aldosterone
  • increased potassium
  • elevated BUN
  • cerebral infarction
  • palpitations
  • tachycardia
  • vomiting
  • abdominal abnormalities
  • hepatitis
  • pancreatitis
  • cholestasis
  • obstructive jaundice
  • abnormal liver function tests
  • gastroenteritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • belching
  • glossitis
  • oral ulcers
  • stomatitis
  • gallbladder pain
  • cheilitis
  • gastric and duodenal ulcers
  • dysphagia
  • melena
  • gingival bleeding
  • hypomotility
  • bronchitis
  • rhinitis
  • pneumonia
  • shortness of breath
  • asthma
  • sensory disturbances
  • vertigo
  • photosensitivity reactions
  • drowsiness
  • forgetfulness
  • abnormal dreams
  • decreased libido
  • emotional lability
  • ataxia
  • torticollis
  • facial paralysis
  • hyperactivity
  • depression
  • tension increase
  • myositis
  • myopathy
  • arthritis
  • bursitis
  • synovitis
  • myasthenia gravis
  • tendon contracture
  • elevated CK
  • increased serum myoglobin
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcers
  • erectile dysfunction
  • urinary tract infection
  • frequent urination
  • cystitis
  • hematuria
  • dysuria
  • kidney stones
  • nocturia
  • epididymitis
  • breast fibrocystic changes
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency of urination
  • abnormal ejaculation
  • uterine bleeding
  • colored urine
  • hypoglycemia
  • increased appetite
  • vasomotor edema
  • chest pain
  • angina
  • facial edema
  • fever
  • cervical rigidity
  • generalized edema
  • amblyopia
  • dry eyes
  • refractive errors
  • ocular hemorrhage
  • hearing loss
  • glaucoma
  • dysgeusia
  • taste loss
  • taste distortion
  • sleep disorders
  • amnesia
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes mellitus
  • cognitive impairment
  • severe muscle weakness
  • ophthalmoplegia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius to preserve the efficacy and safety of the medication.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.